Hepatochem is a C-H Activation technology company that clients engage for (a) rapid, single-step synthesis of metabolites [Phase I: N/S-oxidation, N/O-demethylation, hydroxylation, formylation; and, Phase II: Glucuronidation] in up to 100 mg quantities (b) rapid analoging [C-H to C-F, C-OMe, C-OH, and/or C-Me] of late stage lead(s) to help address DMPK liabilities or explore SAR. Hepatochem also sells ‘fully functionalized’ chemistry kits that scientists can use to screen in their own labs for (a) best conditions to synthesize metabolite of interest, (b) Suzuki coupling, © Stille coupling, (d) Buchwald coupling, and (e) amide coupling.